Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type |Pathology location|Pathology Description|
2012-1-1|n/a,n/a|Sequence:1, Age:42,Type:neutrons C-252,Quantity:0.5,Unit:grays,Application:External exposure, Remarks:with Fe filter 0.5 mGy/min total dose 560 mGy|30 (0 in ERA)|Mouse|Mouse, B6C3F1|Female|Juvenile|Lifespan study for tumors|No information on individuals available for this study
2012-1-2|n/a,n/a|Sequence:1, Age:42,Type:neutrons C-252,Quantity:0.5,Unit:grays,Application:External exposure, Remarks:no Fe filter 0.5 mGy/min total dose 750 mGy|30 (0 in ERA)|Mouse|Mouse, B6C3F1|Female|Juvenile|Lifespan study for tumors|No information on individuals available for this study
2012-1-3|n/a,n/a|Sequence:1, Age:42,Type:neutrons C-252,Quantity:0.5,Unit:grays,Application:External exposure, Remarks:n/a|30 (0 in ERA)|Mouse|Mouse, B6C3F1|Female|Juvenile|Lifespan study for tumors|No information on individuals available for this study
2012-1-4|n/a,n/a|Sequence:1, Age:42,Type:none (controls),Quantity:0,Unit:grays,Application:External exposure, Remarks:n/a|30 (0 in ERA)|Mouse|Mouse, B6C3F1|Female|Juvenile|Lifespan study for tumors|No information on individuals available for this study
		
